Guardant Health Inc (NASDAQ:GH) has a beta value of 1.17 and has seen 2.17 million shares traded in the last trading session. The company, currently valued at $4.25B, closed the last trade at $32.65 per share which meant it gained $1.67 on the day or 5.39% during that session. The GH stock price is -13.45% off its 52-week high price of $37.04 and 51.58% above the 52-week low of $15.81. If we look at the company’s 10-day average daily trading volume, we find that it stood at 2.12 million shares traded. The 3-month trading volume is 2.11 million shares.

The consensus among analysts is that Guardant Health Inc (GH) is Buy stock at the moment, with a recommendation rating of 1.42. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 13 have rated it as a Hold, with 13 advising it as a Buy. 0 have rated the stock as Underweight.

Guardant Health Inc (NASDAQ:GH) trade information

Sporting 5.39% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the GH stock price touched $32.65 or saw a rise of 2.39%. Year-to-date, Guardant Health Inc shares have moved 20.70%, while the 5-day performance has seen it change 12.16%. Over the past 30 days, the shares of Guardant Health Inc (NASDAQ:GH) have changed 61.63%. Short interest in the company has seen 10.26 million shares shorted with days to cover at 7.41.

Wall Street analysts have a consensus price target for the stock at $40, which means that the shares’ value could jump 18.38% from current levels. The projected low price target is $36.0 while the price target rests at a high of $125.0. In that case, then, we find that the current price level is -282.85% off the targeted high while a plunge would see the stock gain -10.26% from current levels.

Guardant Health Inc (GH) estimates and forecasts

Figures show that Guardant Health Inc shares have outperformed across the wider relevant industry. The company’s shares have gained 27.94% over the past 6 months, with this year growth rate of 55.61%, compared to 18.00% for the industry.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -8.88% over the past 5 years. Earnings growth for 2024 is a modest 19.46% while over the next 5 years, the company’s earnings are expected to increase by 29.20%.

GH Dividends

Guardant Health Inc is expected to release its next earnings report in December this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

Guardant Health Inc (NASDAQ:GH)’s Major holders

Insiders own 4.56% of the company shares, while shares held by institutions stand at 104.61% with a share float percentage of 109.61%. Investors are also buoyed by the number of investors in a company, with Guardant Health Inc having a total of 383.0 institutions that hold shares in the company. The top two institutional holders are VANGUARD GROUP INC with over 11.64 million shares worth more than $336.07 million. As of 2024-06-30, VANGUARD GROUP INC held 9.5609% of shares outstanding.

The other major institutional holder is BLACKROCK INC., with the holding of over 11.24 million shares as of 2024-06-30. The firm’s total holdings are worth over $324.55 million and represent 9.2332% of shares outstanding.

Also the top two Mutual Funds that are holding company’s shares are Vanguard Specialized-Health Care Fund and Vanguard Total Stock Market Index Fund . As of Jul 31, 2024 , the former fund manager holds about 3.04% shares in the company for having 3.76 shares of worth $122.78 million while later fund manager owns 3.63 shares of worth $118.58 million as of Jun 30, 2024 , which makes it owner of about 2.94% of company’s outstanding stock.